Jonathan C Fox's Net Worth

-$8.79 Thousand

Estimate Recalculated Nov 1, 2024 09:23AM EST

Who is Jonathan C Fox?

Jonathan C Fox does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MyoKardia Inc, Eidos Therapeutics, Inc., and Edgewise Therapeutics, Inc..

SEC CIK

Jonathan C Fox's CIK is 0001655016

Past Insider Trading and Trends

2023 was Jonathan C Fox's most active year for acquiring shares with 3 total transactions. Jonathan C Fox's most active month to acquire stocks was the month of October. 2021 was Jonathan C Fox's most active year for disposing of shares, totalling 2 transactions. Jonathan C Fox's most active month to dispose stocks was the month of December. 2023 saw Jonathan C Fox paying a total of $100,958.16 for 76,711 shares, this is the most they've acquired in one year. In 2021 Jonathan C Fox cashed out on 450,467 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MyoKardia Inc No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.76%
1.81K
$8.50
$15,359.50
241K
Apr 29
Form 4
+1.27%
3K
$10.00
$30,000.00
239.19K
Nov 3
Form 3
—
0
—
—
0
No matching records found

Eidos Therapeutics, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-380.97K
—
—
0
Dec 28 - Jan 26
Form 4
-1.50%
-5.77K
$50.16
-$289,258.88
377.67K
Scheduled
Sep 17
Form 4
-1.09%
-4.23K
$50.14
-$212,223.51
383.44K
Scheduled
Sep 14 - Sep 16
Form 4
-1.27%
-5.00K
$50.00
-$250,000.00
387.67K
Scheduled
Jul 7
Form 4
+0.28%
1.09K
—
—
392.67K
Jun 29
Form 4
-1.64%
-6.60K
$45.79
-$231,541.37
394.88K
Scheduled
May 31 - Jun 3
Form 4
-1.24%
-5.00K
$50.00
-$250,000.00
398.63K
Scheduled
May 28
Form 4
-1.22%
-5.00K
$50.00
-$250,000.00
403.63K
Scheduled
Apr 23 - Apr 24
Form 4
-2.39%
-10.00K
$51.57
-$515,706.00
408.63K
Mar 2
Form 4
-2.70%
-11.63K
$54.00
-$540,000.00
418.63K
Feb 4 - Feb 13
Form 4
-2.27%
-10.00K
$55.01
-$550,071.90
430.26K
Jan 14 - Jan 15
Form 4
-0.06%
-270.00
—
—
440.26K
Dec 26 - Dec 30
Form 4
-2.44%
-11.00K
$58.90
-$589,048.00
440.53K
Nov 26 - Dec 4
Form 4
-2.17%
-10.00K
$56.52
-$565,218.00
451.53K
Nov 25
Form 4
-2.12%
-10.00K
$55.11
-$551,073.00
461.53K
Nov 21
Form 4
-3.08%
-15.00K
$48.65
-$729,703.42
471.53K
Scheduled
Nov 15 - Nov 18
Form 4
-1.02%
-5.00K
$36.16
-$180,817.59
486.53K
Scheduled
Oct 15
Form 4
-1.01%
-5.00K
$45.74
-$228,722.00
491.53K
Scheduled
Sep 16
Form 4
-1.00%
-5.00K
$38.72
-$193,595.84
496.53K
Scheduled
Aug 15
Form 4
-2.56%
-13.23K
$26.03
-$579,314.43
504.38K
May 31 - Jul 15
Form 4
-0.96%
-5.00K
$32.64
-$163,178.50
516.53K
May 30
Form 4
-0.95%
-5.00K
$25.03
-$125,150.00
521.53K
May 3
Form 4
-0.74%
-3.92K
$18.74
-$114,303.87
527.61K
Nov 30 - May 1
Form 4
-0.93%
-5.00K
$23.11
-$115,550.00
531.53K
Apr 15
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 10
Form 4
∞
10.86K
$9.30
$100,958.16
10.86K
Dec 26
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Mar 3
Form 3
—
0
—
—
0
No matching records found